Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 7Terminated 3Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Lymphoma, Non-Hodgkin 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Lymphoma 3Leukemia, Biphenotypic, Acute 3Hodgkin Disease 3Burkitt Lymphoma 3Lymphoma, Mantle-Cell 2Leukemia, Myelomonocytic, Juvenile 2Anemia, Refractory, with Excess of Blasts 2Teratoma 1Seminoma 1Sarcoma, Myeloid 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Nonseminomatous germ cell tumor 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Multi-centric Castleman's Disease 1Medulloblastoma 1Macular dystrophy, corneal type 1 1

Interventions

Magnetic Resonance Spectroscopy 9Cyclophosphamide 8Specimen Handling 7X-Rays 6Phantoms, Imaging 6Vincristine 5Nuclear Medicine Department, Hospital 5Cisplatin 5Temozolomide 4Radiotherapy 4Biopsy 4Lomustine 3Etoposide 3Carboplatin 3ulixertinib 2tipifarnib 2selpercatinib 2pembrolizumab 2palbociclib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Radiation 2Platinum 2Irinotecan 21,2-diaminocyclohexaneplatinum II citrate 2tazemetostat 1omburtamab I-131 1olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Medulloblastoma × Granulocyte Colony-Stimulating Factor × Clear all
NCT00392327 2025-06-13

Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET

Children's Oncology Group

Phase 3 Active not recruiting
379 enrolled 29 charts
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡